EUVIMEDEUVIMED entdecken
KommentarOpen Access

Discovery of new antigens for serodiagnosis of visceral leishmaniasis in humans and dogs adds valuable tools to our arsenal

Eva Iniguez iD, Shaden Kamhawi iD

mBio · 2024

DOI: 10.1128/mbio.01079-24 ↗

Kurz gefasst

Kommentar in der Zeitschrift mBio, 2024. Verfasst von Eva Iniguez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institut…. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Antigens, Protozoan, Serologic Tests, Dog Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural Research Program of NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surveillance and sustained control of visceral leishmaniasis (VL) require reliable serodiagnostic tools. rK39, the gold standard antigen for VL diagnosis, is limited by its documented poor sensitivity in certain endemic regions, such as East Africa, and by the longevity of its antibodies, making it difficult to distinguish active from cured infections. In a recent publication in mBio , Roberts et al. (A. J. Roberts, H.B. Ong, S. Clare, C. Brandt, et al., mBio 15:e00859-24, 2024, https://doi.org/10.1128/mbio.00859-24 ) identified new immunogenic Leishmania candidates in dogs and humans. In dogs, combined antigens LdBPK_290790.1 + LdBPK_362700.1 (D4 +D46) distinguished symptomatic from asymptomatic infections. For humans, LdBPK_323600.1 (D36) antigen produced short-lived antibodies and performed well in patient cohorts from Bangladesh and Ethiopia, but not Kenya. This study adds promising new candidates to our serodiagnostic toolbox but highlights the need for more antigen discovery studies that may have to be focused on regional performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, VisceralAntigens, ProtozoanSerologic TestsDog DiseasesAntibodies, ProtozoanDogsAnimalsHumansSensitivity and SpecificityEthiopia

Stichwörter der Autor:innen

antibody durationantibody titerasymptomatic infectiondiagnostic toolsdoghumanserologysymptomatic infectionvisceral leishmaniasis

Substanzen

Antigens, ProtozoanAntibodies, Protozoan

Autor:innen und Institutionen

  • Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.

ORCID-Profile: Eva Iniguez, Shaden Kamhawi

Förderung

  • Intramural Research Program of NIAID

Zitieren

APA

Iniguez, E., & Kamhawi, S. (2024). Discovery of new antigens for serodiagnosis of visceral leishmaniasis in humans and dogs adds valuable tools to our arsenal. mBio. https://doi.org/10.1128/mbio.01079-24

Vancouver

Iniguez E, Kamhawi S. Discovery of new antigens for serodiagnosis of visceral leishmaniasis in humans and dogs adds valuable tools to our arsenal. mBio. 2024. doi:10.1128/mbio.01079-24

BibTeX
@article{Iniguez2024,
  author = {Iniguez, Eva and Kamhawi, Shaden},
  title = {Discovery of new antigens for serodiagnosis of visceral leishmaniasis in humans and dogs adds valuable tools to our arsenal},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.01079-24}
}
Kostenlos starten →